Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd

Bullboard Posts

Comment by Desteekon Apr 24, 2020 4:58am

150 Views

Post# 30948113

RE:Buying opportunity as marketcap is wrong

Hi, I agree with you here. This is a ridiculous share price for a company with so much potential.
As you said, if the FDA is willing to pass Phase2 trial and push this forward to Phase 3 this must look very promising. I will do my DD and consider a LT position. Tnx for sharing your thoughts on this. GL, stay safe

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025